China Medical & HealthCare Group Limited (COLRF) Comparison with companies in other sectors?

China Medical & HealthCare Group Limited has a share price of 1.57B. You can analyze China Medical & HealthCare Group Limited (COLRF) competitors across different market sectors through stock heatmaps.

What are COLRF's NET and operating margins?

China Medical & HealthCare Group Limited (COLRF) operating margin is around 0.06, and net profit margin is approximately 0.02 as of the latest reports.

In what way does COLRF's earnings per share (EPS) trend reflect its financial momentum?

China Medical & HealthCare Group Limited (COLRF) EPS is -0.01 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for China Medical & HealthCare Group Limited is -8.00, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for China Medical & HealthCare Group Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for China Medical & HealthCare Group Limited like P/E which is 24.20, P/B which is 0.37, and PEG which is 0.06. Compare them with sector averages to evaluate if the stock is priced fairly.

China Medical & HealthCare Group Limited

COLRF•PNK

Healthcare

Medical - Care Facilities

$0.08

$0.00(0.00%)

Fundamental Analysis of China Medical & HealthCare Group Limited (COLRF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.01

P/E Ratio

-8.00

ROE

0.02%

Net Margin

0.02%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$125.53M

Shares OutstandingTotal number of shares issued

$1.57B

Book Value/ShareNet worth per share

$1.74

Revenue/ShareAnnual revenue per share

$1.13

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.01

Net MarginNet income as percentage of revenue

2.30%

Operating MarginOperating income as percentage of revenue

6.07%

ROEReturn on shareholders' equity

1.54%

ROAReturn on total assets

0.80%

ROCEReturn on capital employed

3.13%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.04

Cash/ShareCash and equivalents per share

$0.82

FCF YieldFree cash flow as percentage of market cap

4.73%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.02

Dividend YieldAnnual dividend as percentage of stock price

3.18%

Financial Ratios Analysis data is not available for COLRFFinancial Ratios Analysis details for COLRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for COLRFSector Benchmarking details for COLRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for China Medical & HealthCare Group Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of China Medical & HealthCare Group Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account China Medical & HealthCare Group Limited's unique business strengths and challenges.

Key Financial Metrics for China Medical & HealthCare Group Limited

For China Medical & HealthCare Group Limited, essential financial indicators include EPS -0.01, PE -8.00, and ROE 0.02. These key ratios reveal insights into China Medical & HealthCare Group Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare China Medical & HealthCare Group Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of China Medical & HealthCare Group Limited

Metrics like Net Margin 2.30% and ROA 0.80% shed light on how well China Medical & HealthCare Group Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether China Medical & HealthCare Group Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of China Medical & HealthCare Group Limited

Using ratios such as P/B Ratio 0.37 and PEG Ratio 0.06, investors can assess whether China Medical & HealthCare Group Limited is appropriately valued based on its financials and growth potential. These figures, combined with China Medical & HealthCare Group Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for China Medical & HealthCare Group Limited

Financial health indicators, such as Debt/Equity Ratio 0.46 and Cash Flow $0.04, provide a snapshot of China Medical & HealthCare Group Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like China Medical & HealthCare Group Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for China Medical & HealthCare Group Limited

Investing in China Medical & HealthCare Group Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at China Medical & HealthCare Group Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;